$KALV

KalVista Pharmaceuticals insider Nicole Sweeny sold 1,489 shares on May 26 at an average $26.78, raising $39,875.42, to cover tax withholding tied to equity vesting, according to an SEC filing. After the sale, she held 59,291 shares. The article also cites prior sales and notes the stock traded around $26.79 after May 14 earnings.